- Home
- XENE vs GNTX Comparison
XENE vs GNTX Comparison
Compare XENE & GNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | GNTX |
|---|---|---|
| Founded | 1996 | 1974 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.0B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XENE | GNTX |
|---|---|---|
| Price | $57.66 | $22.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | ★ $68.55 | $26.60 |
| AVG Volume (30 Days) | 800.0K | ★ 2.1M |
| Earning Date | 05-08-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.74 |
| Revenue | $311,000.00 | ★ $2,534,268,965.00 |
| Revenue This Year | N/A | $6.89 |
| Revenue Next Year | $2,496.48 | $4.58 |
| P/E Ratio | ★ N/A | $13.07 |
| Revenue Growth | N/A | ★ 9.55 |
| 52 Week Low | $28.19 | $20.48 |
| 52 Week High | $62.91 | $29.38 |
Technical Indicators
Market Signals| Indicator | XENE | GNTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 49.18 |
| Support Level | $39.93 | $21.17 |
| Resistance Level | $59.71 | $25.01 |
| Average True Range (ATR) | 1.90 | 0.67 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 66.29 | 31.96 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.